닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Oldfield Mike]

23건 중 23건 출력

, 1/3 페이지

  • 1
    Kinetics of heat-induced whey protein denaturation and aggregation in skim milks with adjusted whey protein concentration
    Oldfield, David J; Singh, Harjinder; Taylor, Mike W; ; (The Journal of dairy research, v.72, 2005, pp.369-378)
  • 2
    Cannabidiol Prescription Requests in NZ: Describing Patients and Indications Seen in a New Zealand Cannabis Clinic
    Gulbransen Graham; Oldfield Karen; Braithwaite Irene; Sinclair Justin; Xu William; Arroll Bruce; Eathorne Allie; Armour Mike; CannabisCare NZ; Medical Research Institute of New Zealand; Medical Research Institute of New Zealand; NICM Health Research Institute, Western Sydney University; University of Auckland; University of Auckland; Medical Research Institute of New Zealand; Translational Health Research Institute, Western Sydney University; (, v., 2022, )
  • 3
    Book Reviews
    Helms, Gesa; Hebbert, Michael; Holgate, Jane; Leibovitz, Joseph; Raco, Mike; Oldfield, Jonathan; Whitelegg, John; Parsons, Nick; Daly, Gerald; Department of Urban Studies University of Glasgow; University of Manchester; Department of Geography Queen Mary, University of London; Institute of Geography University of Edinburgh; Department of Geography University of Reading; School of Geography, Earth and Environmental SciencesUniversity of Birmingham; Stockholm Environment Institute University of York; Cardiff University; York University Toronto; (Urban studies, v.42, 2005, pp.801-816)
  • 4
    The transcription factor PU.1 is critical for viability and function of human brain microglia
    Smith, Amy M.; Gibbons, Hannah M.; Oldfield, Robyn L.; Bergin, Peter M.; Mee, Edward W.; Faull, Richard L. M.; Dragunow, Mike; Department of Pharmacology and Clinical Pharmacology, the University of Auckland, Auckland, New Zealand; Department of Pharmacology and Clinical Pharmacology, the University of Auckland, Auckland, New Zealand; Lab Plus, Auckland, New Zealand; Center for Brain Research, the University of Auckland, Auckland, New Zealand; Center for Brain Research, the University of Auckland, Auckland, New Zealand; Center for Brain Research, the University of Auckland, Auckland, New Zealand; Department of Pharmacology and Clinical Pharmacology, the University of Auckland, Auckland, New Zealand; (GLIA, v.61, 2013, pp.929-942)
  • 5
    A role for human brain pericytes in neuroinflammation
    Jansson, Deidre; Rustenhoven, Justin; Feng, Sheryl; Hurley, Daniel; Oldfield, Robyn L; Bergin, Peter S; Mee, Edward W; Faull, Richard LM; Dragunow, Mike; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, 85 Park Road, Auckland 1023, New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, 85 Park Road, Auckland 1023, New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, 85 Park Road, Auckland 1023, New Zealand; Department of Molecular Medicine and Pathology, The University of Auckland, Bldg 504, 85 Park Road, Auckland 1023, New Zealand; LabPLUS, Auckland City Hospital, Bldg 31, Gate 4 Grafton Road, Auckland 1148, New Zealand; Centre for Brain Research, The University of Auckland, Bldg 503, 85 Park Road, Auckland 1023, New Zealand; Centre for Brain Research, The University of Auckland, Bldg 503, 85 Park Road, Auckland 1023, New Zealand; Department of Anatomy with Radiology, The University of Auckland, Bldg 505, 85 Park Road, Auckland 1023, New Zealand; Department of Pharmacology and Clinical Pharmacology, The University; (Journal of neuroinflammation, v.11, 2014, pp.104-104)
  • 6
    Erratum to: A role for human brain pericytes in neuroinflammation
    Jansson, Deidre; Rustenhoven, Justin; Feng, Sheryl; Hurley, Daniel; Oldfield, Robyn L.; Bergin, Peter S.; Mee, Edward W.; Faull, Richard L. M.; Dragunow, Mike; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, 85 Park Road, Auckland, 1023 New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, 85 Park Road, Auckland, 1023 New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, 85 Park Road, Auckland, 1023 New Zealand; Department of Molecular Medicine and Pathology, The University of Auckland, Bldg 504, 85 Park Road, Auckland, 1023 New Zealand; LabPLUS, Auckland City Hospital, Bldg 31, Gate 4 Grafton Road, Auckland, 1148 New Zealand; Centre for Brain Research, The University of Auckland, Bldg 503, 85 Park Road, Auckland, 1023 New Zealand; Centre for Brain Research, The University of Auckland, Bldg 503, 85 Park Road, Auckland, 1023 New Zealand; Department of Anatomy with Radiology, The University of Auckland, Bldg 505, 85 Park Road, Auckland, 1023 New Zealand; Department of Pharmacology and Clinical Pharmacology, The University; (Journal of neuroinflammation, v.12, 2015, pp.213)
  • 7
    M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia
    Smith, Amy M; Gibbons, Hannah M; Oldfield, Robyn L; Bergin, Peter M; Mee, Edward W; Curtis, Maurice A; Faull, Richard L M; Dragunow, Mike; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; Lab Plus, Auckland 1023, New Zealand; Center for Brain Research, The University of Auckland, Auckland, New Zealand; Center for Brain Research, The University of Auckland, Auckland, New Zealand; Department of Anatomy, The University of Auckland, Auckland, New Zealand; Department of Anatomy, The University of Auckland, Auckland, New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand; (Journal of neuroinflammation, v.10, 2013, pp.85-85)
  • 8
    Distinct characteristics of microglia from neurogenic and non-neurogenic regions of the human brain in patients with Mesial Temporal Lobe Epilepsy
    Smith, Amy M.; Park, Thomas In-Hyeup; Aalderink, Miranda; Oldfield, Robyn L.; Bergin, Peter S.; Mee, Edward W.; Faull, Richard L. M.; Dragunow, Mike; Department of Pharmacology and Clinical Pharmacology, The University of Auckland , Auckland , New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland , Auckland , New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland , Auckland , New Zealand; LabPLUS , Auckland , New Zealand; Centre for Brain Research, The University of Auckland , Auckland , New Zealand; Centre for Brain Research, The University of Auckland , Auckland , New Zealand; Centre for Brain Research, The University of Auckland , Auckland , New Zealand; Department of Pharmacology and Clinical Pharmacology, The University of Auckland , Auckland , New Zealand; (Frontiers in cellular neuroscience, v.16, 2022, pp.1047928)
  • 9
    Optimization of Molecular Approaches to Genogroup <i>Neisseria meningitidis</i> Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines
    Rojas, Eduardo; Hoyos, Johanna; Oldfield, Neil J.; Lee, Philip; Flint, Mike; Jones, C. Hal; Ala’Aldeen, Dlawer A. A.; Jansen, Kathrin U.; Anderson, Annaliesa S.; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, United States of America; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, United States of America; School of Life Sciences, University of Nottingham, Nottingham, United Kingdom; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, United States of America; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, United States of America; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, United States of America; School of Life Sciences, University of Nottingham, Nottingham, United Kingdom; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, United States of America; Vaccine Research and Development, Pfizer Inc, Pearl River, New York, United States of America; (PloS one, v.10, 2015, pp.e0132140)
  • 10
    β-Lactam antimicrobial pharmacokinetics and target attainment in critically ill patients aged 1 day to 90 years: the ABDose study
    Lonsdale, Dagan O; Kipper, Karin; Baker, Emma H; Barker, Charlotte I S; Oldfield, Isobel; Philips, Barbara J; Johnston, Atholl; Rhodes, Andrew; Sharland, Mike; Standing, Joseph F; Institute for Infection and Immunity, St George’s, University of London , London, UK; Institute for Infection and Immunity, St George’s, University of London , London, UK; Institute for Infection and Immunity, St George’s, University of London , London, UK; Institute for Infection and Immunity, St George’s, University of London , London, UK; Institute for Infection and Immunity, St George’s, University of London , London, UK; Brighton and Sussex Medical School , Brighton, UK; Analytical Services International Ltd , London, UK; St George’s University Hospitals NHS Foundation Trust , London, UK; Institute for Infection and Immunity, St George’s, University of London , London, UK; Institute for Infection and Immunity, St George’s, University of London , London,; (The Journal of antimicrobial chemotherapy, v.75, 2020, pp.3625-3634)
123

처음 오셨나요?